Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1994 Nov;53(11):755–758. doi: 10.1136/ard.53.11.755

HLA-B alleles and complotypes in Mexican patients with seronegative spondyloarthropathies.

G Vargas-Alarcón 1, A Garcia 1, S Bahena 1, H Melin-Aldana 1, F Andrade 1, G Ibañez-de-Kasep 1, J Alcocer-Varela 1, D Alarcón-Segovia 1, J Granados 1
PMCID: PMC1005457  PMID: 7826137

Abstract

OBJECTIVES--To analyse major histocompatibility complex (MHC) haplotypes in Mexican mestizo patients with seronegative spondyloarthropathies (SSpA) and normal controls, to discover if there are other antigens, besides B27, in the HLA region that might show association with the disease. METHODS--The study included 100 Mexican mestizo patients with SSpA and 200 of their first degree relatives. These groups were compared with 85 ethnically matched controls. The class I and class III MHC antigens were obtained by standard methods. The significance of differences between patients and controls was tested by chi 2 analysis; linkage disequilibrium among the different alleles in each haplotype was estimated by computing delta values. RESULTS--We found a significantly increased frequency of the HLA-B27 antigen (pcorr. = 1 x 10(-5), odds ratio (OR) = 33.4, 95% confidence interval (CI) = 9.3-142.0). In the group of 45 SSpA patients negative for the B27 antigen, independent increased frequencies of HLA-B49 antigen (pcorr. = 0.03, OR = 6.5, 95% CI = 1.5-32.8)) and the FC31 complotype (pcorr. = 0.04, OR = 3.7, 95% CI = 1.2-11.1) were found. Significant delta values were obtained for the [B27;SC30] haplotype (p = 0.0005) but not for haplotypes marked by the FC31 complotype. HLA-B antigens on the homologous chromosome in B27 positive patients were mainly HLA-B51 (18%) and HLA-B60 (16%); however, the observed genotypes B27/B51 and B27/B60 were not significantly different than expected from the allele frequencies alone. CONCLUSIONS--These data suggest that in Mexicans additional genes within the MHC region besides the HLA-B27 antigen, might be related to the genetic susceptibility for developing SSpA. Relevant antigens included the HLA-B49 and the FC31 complotype.

Full text

PDF
755

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alper C. A., Boenisch T., Watson L. Genetic polymorphism in human glycine-rich beta-glycoprotein. J Exp Med. 1972 Jan;135(1):68–80. doi: 10.1084/jem.135.1.68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alper C. A. Inherited structural polymorphism in human C2: evidence for genetic linkage between C2 and Bf. J Exp Med. 1976 Oct 1;144(4):1111–1115. doi: 10.1084/jem.144.4.1111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Awdeh Z. L., Alper C. A. Inherited structural polymorphism of the fourth component of human complement. Proc Natl Acad Sci U S A. 1980 Jun;77(6):3576–3580. doi: 10.1073/pnas.77.6.3576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Benjamin R., Parham P. Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol Today. 1990 Apr;11(4):137–142. doi: 10.1016/0167-5699(90)90051-a. [DOI] [PubMed] [Google Scholar]
  5. Breur-Vriesendorp B. S., Dekker-Saeys A. J., Ivanyi P. Distribution of HLA-B27 subtypes in patients with ankylosing spondylitis: the disease is associated with a common determinant of the various B27 molecules. Ann Rheum Dis. 1987 May;46(5):353–356. doi: 10.1136/ard.46.5.353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brewerton D. A. Joseph J. Bunim Memorial Lecture. HLA-B27 and the inheritance of susceptibility to rheumatic disease. Arthritis Rheum. 1976 Jul-Aug;19(4):656–668. doi: 10.1002/1529-0131(197607/08)19:4<656::aid-art1780190402>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  7. Böyum A. Isolation of leucocytes from human blood. Further observations. Methylcellulose, dextran, and ficoll as erythrocyteaggregating agents. Scand J Clin Lab Invest Suppl. 1968;97:31–50. [PubMed] [Google Scholar]
  8. Calin A., Fries J. F. Striking prevalence of ankylosing spondylitis in "healthy" w27 positive males and females. N Engl J Med. 1975 Oct 23;293(17):835–839. doi: 10.1056/NEJM197510232931701. [DOI] [PubMed] [Google Scholar]
  9. Deverson E. V., Gow I. R., Coadwell W. J., Monaco J. J., Butcher G. W., Howard J. C. MHC class II region encoding proteins related to the multidrug resistance family of transmembrane transporters. Nature. 1990 Dec 20;348(6303):738–741. doi: 10.1038/348738a0. [DOI] [PubMed] [Google Scholar]
  10. Dougados M., van der Linden S., Juhlin R., Huitfeldt B., Amor B., Calin A., Cats A., Dijkmans B., Olivieri I., Pasero G. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum. 1991 Oct;34(10):1218–1227. doi: 10.1002/art.1780341003. [DOI] [PubMed] [Google Scholar]
  11. Khan M. A. Ankylosing spondylitis and heterogeneity of HLA-B27. Semin Arthritis Rheum. 1988 Nov;18(2):134–141. doi: 10.1016/0049-0172(88)90006-6. [DOI] [PubMed] [Google Scholar]
  12. Khan M. A., Kellner H. Immunogenetics of spondyloarthropathies. Rheum Dis Clin North Am. 1992 Nov;18(4):837–864. [PubMed] [Google Scholar]
  13. Khan M. A., Khan M. K. Diagnostic value of HLA-B27 testing ankylosing spondylitis and Reiter's syndrome. Ann Intern Med. 1982 Jan;96(1):70–76. doi: 10.7326/0003-4819-96-1-70. [DOI] [PubMed] [Google Scholar]
  14. Khan M. A., Kushner I., Braun W. E. A subgroup of ankylosing spondylitis associated with HLA-B7 in American blacks. Arthritis Rheum. 1978 Jun;21(5):528–530. doi: 10.1002/art.1780210506. [DOI] [PubMed] [Google Scholar]
  15. Lisker R., Perez-Briceño R., Granados J., Babinsky V., de Rubens J., Armendares S., Buentello L. Gene frequencies and admixture estimates in a Mexico City population. Am J Phys Anthropol. 1986 Oct;71(2):203–207. doi: 10.1002/ajpa.1330710207. [DOI] [PubMed] [Google Scholar]
  16. Lisker R., Pérez-Briceno R., Granados J., Babinsky V. Gene frequencies and admixture estimates in the state of Puebla, Mexico. Am J Phys Anthropol. 1988 Jul;76(3):331–335. doi: 10.1002/ajpa.1330760307. [DOI] [PubMed] [Google Scholar]
  17. Lisker R., Ramirez E., Briceño R. P., Granados J., Babinsky V. Gene frequencies and admixture estimates in four Mexican urban centers. Hum Biol. 1990 Dec;62(6):791–801. [PubMed] [Google Scholar]
  18. Lochead J. A., Chalmers I. M., Marshall W. H., Larsen B., Skanes V. M., Payne R. H., Barnard J. M. HLA-B27 haplotypes in family studies of ankylosing spondylitis. Arthritis Rheum. 1983 Aug;26(8):1011–1016. doi: 10.1002/art.1780260810. [DOI] [PubMed] [Google Scholar]
  19. Monaco J. J. A molecular model of MHC class-I-restricted antigen processing. Immunol Today. 1992 May;13(5):173–179. doi: 10.1016/0167-5699(92)90122-N. [DOI] [PubMed] [Google Scholar]
  20. Monaco J. J., Cho S., Attaya M. Transport protein genes in the murine MHC: possible implications for antigen processing. Science. 1990 Dec 21;250(4988):1723–1726. doi: 10.1126/science.2270487. [DOI] [PubMed] [Google Scholar]
  21. Robinson W. P., van der Linden S. M., Khan M. A., Rentsch H. U., Cats A., Russell A., Thomson G. HLA-Bw60 increases susceptibility to ankylosing spondylitis in HLA-B27+ patients. Arthritis Rheum. 1989 Sep;32(9):1135–1141. doi: 10.1002/anr.1780320912. [DOI] [PubMed] [Google Scholar]
  22. Schlosstein L., Terasaki P. I., Bluestone R., Pearson C. M. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med. 1973 Apr 5;288(14):704–706. doi: 10.1056/NEJM197304052881403. [DOI] [PubMed] [Google Scholar]
  23. Spies T., Bresnahan M., Bahram S., Arnold D., Blanck G., Mellins E., Pious D., DeMars R. A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway. Nature. 1990 Dec 20;348(6303):744–747. doi: 10.1038/348744a0. [DOI] [PubMed] [Google Scholar]
  24. Stein M., Davis P., Emmanuel J., West G. The spondyloarthropathies in Zimbabwe: a clinical and immunogenetic profile. J Rheumatol. 1990 Oct;17(10):1337–1339. [PubMed] [Google Scholar]
  25. Säfwenberg J., Domeij-Nyberg B., Kjällman M. HLA antigens in females with ankylosing spondylitis and other forms of seronegative rheumatic diseases. Scand J Rheumatol. 1978;7(3):177–182. doi: 10.3109/03009747809095650. [DOI] [PubMed] [Google Scholar]
  26. TERASAKI P. I., MCCLELLAND J. D. MICRODROPLET ASSAY OF HUMAN SERUM CYTOTOXINS. Nature. 1964 Dec 5;204:998–1000. doi: 10.1038/204998b0. [DOI] [PubMed] [Google Scholar]
  27. Wagener P., Zeidler H., Eckert G., Deicher H. Increased frequency of HLA-Bw62 and Bw35 CREG antigens in HLA-B27 negative ankylosing spondylitis. Z Rheumatol. 1984 Sep-Oct;43(5):253–257. [PubMed] [Google Scholar]
  28. Woodrow J. C. Histocompatibility antigens and rheumatic diseases. Semin Arthritis Rheum. 1977 Feb;6(3):257–276. doi: 10.1016/0049-0172(77)90023-3. [DOI] [PubMed] [Google Scholar]
  29. van den Berg-Loonen E. M., Dekker-Saeys B. J., Meuwissen S. G., Nijenhuis L. E., Engelfriet C. P. Histocompatibility antigens and other genetic markers in ankylosing spondylitis and inflammatory bowel diseases. J Immunogenet. 1977 Jun;4(3):167–175. doi: 10.1111/j.1744-313x.1977.tb00899.x. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES